2021 annual financial data

TScan Therapeutics 2021 Financial results

Direct answer

Revenue was 10.14M USD.

Operating income was -48.64M USD and net income was -48.63M USD.
Operating cash flow was -48.68M USD.

Get free TScan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10.14M USD
Operating income
-48.64M USD
Net income
-48.63M USD
Operating cash flow
-48.68M USD